PATENT
EP3666797
ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
Court proceedings (1)
- 2026-03-25and Regeneron Pharmaceuticals Inc., SANOFI-AVENTIS GROUPE S.A. +2 v. AMGEN, INC, One Amgen Center Drive, AMGEN, INC
ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)